Intelligence Platform
Patents
Browse 29,054 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11618784
Anti-CD47 combination therapy
granted patentUS 11617755
Pharmaceutical compositions comprising meloxicam
granted patentUS 11617756
Pharmaceutical compositions comprising meloxicam
granted patentUS 11617761
Methods for treating NLRP3 inflammasome-associated diseases, and methods of identifying ag
granted patentUS 11617766
Notch receptors with hinge domain
granted patentUS 11617753
Methods of treating and inhibiting Ebola virus infection
granted patentUS 11618731
Prodrugs of kallikrein inhibitors
granted patentUS 11618733
Crystalline salts of a plasma kallikrein inhibitor
granted patentUS 11618746
Inhibitors of APOL1 and methods of using same
granted patentUS 11612657
Biodegradable lipids for the delivery of active agents
granted patentUS 11612662
Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds
granted patentUS 11612608
Methods of treating oral mucositis
granted patentUS 11612663
Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair
granted patentUS 11612870
Microencapsulation of chemicals and bioactives by in situ complex coacervation during spra
granted patentUS 11612675
Fish skin biologic bandage
granted patentUS 11613502
Core-shell ceramic particle colloidal gel and solid oxide fuel cell electrolyte
granted patentUS 11613538
Method of inhibiting or reducing a viral infection
granted patentUS 11613527
Enzyme inhibitors
granted patentUS 11613511
Methods of making bempedoic acid and compositions of the same
granted patentUS 11613528
Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use
granted patentUS 11612652
Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dend
granted patentUS 11613735
Methods for reprograming non-hepatocyte cells into hepatocyte cells
granted patentUS 11612575
Combination therapies with disulfiram
granted patentUS 11613754
Toxic RNAi active seed sequences for killing cancer cells
granted